Серцева недостатність зі збереженою фракцією викиду: фантом чи реальний самостійний синдром із "власним обличчям"?

Ather S, Chan W, Bozkurt B et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59 (11):998-1005. Doi:10.1016/j.jacc.2011.11.040

Bhatia RS, Tu JV, Lee DS et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260-269.

Borlaug BA, Lam CS, Roger VL et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol. 2009;54:410-148. doi: 10.1016/j.jacc.2009.05.013

Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006-2013. doi: 10.1161/CIRCULATIONAHA.110.954388.

Bursi F, Weston SA, Redfield MM et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209-2216.

Campbell RT, Jhund PS, Castagno D et al. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-PRESERVED, and I-PRESERVE?. J Am Coll Cardiol. 2012;60:2349-2356. doi: 10.1016/j.jacc.2012.04.064.

Chan MM.Y., Lam CS.P. How do patients with heart failure with preserved ejection fraction die?. Eur J Heart Fail. 2013;15(6):604-13.10.1093/eurjhf/hft062

European Study Group on Diastolic Heart Failure How to diagnose diastolic heart failure. Eur Heart J. 1998;19:990-1003.

Fonarow GC, Stough WG, Abraham WT et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol. 2007;50:768-777. doi:10.1016/j. jack.2007.04.064

Gerber Y, Weston SA, Redfield M, Chamberlain AM. A contemporary appraisal of the heart failure epidemic in olmstead county, Minnesota, 2000-2010. JAMA. Intern. Med. 2015;176:996-1004. doi: 10.1001/jamainternmed.2015.0924

Go AS, Mozaffarian D, Roger VL et al. Heart disease and stroke statistics -2013 update: A report from the american heart association. Circulation. 2013;127. P. e6–e245. doi: 10.1161/CIR.0b013e31828124ad.

Gonzalez A, Lopez B, Querejeta R et al. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension. 2010;55:1418-1424. doi: 10.1161/HYPERTENSIONAHA.109.149112

Goyal P, Almar 2000 Z. I., Horn EM et al. Characteristics of hospitalizations for heart failure with preserved ejection fraction. Am J Med. icine. 2016;129. P. e615-635. e 26 doi: 10.1016/j.amjmed.2016.02.007.

Henkel DM, Redfield MM,Weston SA et al. Death in heart failure: a community perspective. Circ Heart Fail. 2008;1:91-97. doi: 10.1161/CIRCHEARTFAILURE.107.743146.

Hoekstra T, Lesman-Leegte I, van Veldhuisen DJ et al. Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2011;13:1013-1018. doi: 10.1093/eurjhf/hfr072.

Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003;107:714-720.

Lam CS.P., Roger VL, Rodeheffer RJ et al. Pulmonary hypertension in heart fail-ure with preserved ejection fraction. J Am Coll Cardiol. 2009;5:1119-1126.

Lam CS, Lyass A, Kraigher-Krainer E et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation. 2011;124:24-30. doi: 10.1161/CIRCULATIONAHA.110.979203.

Lewis EF, Lamas GA, O’Meara E et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in charm. Eur J Heart Fail. 2007;9:83-91.

Lopez B, Gonzalez A, Dıez J. Circulating biomarkers of collagen metabolism in cardiac diseases. Circulation. 2010;121:1645-1654. doi: 10.1161/CIRCULATIONAHA.109.912774.

Mohammed SF, Borlaug BA, Roger VL et al. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail. 2012;5:710-719. doi: 10.1161/CIRCHEARTFAILURE.112.968594.

Mangla A. Kane J, Beaty E et al. Comparison of predictors of heart failure-related hospitalization or death in patients with versus without preserved left ventricular ejection fraction. Am J Cardiol. 2013;112:1907-1912. doi: 10.1016/j.amjcard.2013.08.014.

Nagueh SF, Appleton CP, Gillebert TC. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22 — P. 107-133. doi: 10.1016/j.echo.2008.11.023

Owan TE, Hodge DO, Herges RM et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251-259.

Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263-271. doi: 10.1016/j.jacc.2013.02.092.

Ponikowski P, Voors AA, Anker SD et al. | 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J- — 2016;37:2129-2200. doi: 10.1093/eurheartj/ehw 128. doi: 10.1093/eurheartj/ehw 128.

Prasad A, Hastings JL, Shibata S et al. Characterization of static and dynamic left ventricular diastolic function in patients with heart failurewith a preservedejection fraction. Circ Heart Fail. 2010;3:617-626. doi: 10.1161/CIRCHEARTFAILURE.109.867044.

Rame JE, Ramilo M, Spencer N et al. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol. 2004;93:234-237.

Redfield M. Heart failure with preserved ejection fraction. N Engl J Med- — 2016;375:1868-1877. DOI: 10.1056/NEJMcp1511175

Redfield MM, Jacobsen SJ, Burnett JC. Jr. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202.

Schwartzenberg S, Redfield MM, From AM et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012;59:442-451. doi: 10.1016/j.jacc.2011.09.062

Solomon SD, Anavekar N, Skali H et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738-3744.

Tribouilloy C, Rusinaru D, Mahjoub H et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J. 2008;29(3):339-347. doi: 10.1093/eurheartj/ehm554.

van Heerebeek L, Hamdani N, Falcao-Pires I et al. Low myocardial protein kinase g activity in heart failure with preserved ejection fraction. Circulation. 2012;126(7):830-839. doi: 10.1161/circulationaha.111.076075.

Westermann D, Kasner M, Steendijk P et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008;117 (16):2051-2060. doi: 10.1161/circulationaha.107.716886.

Zile MR, Baicu CF, Gaasch WH. Diastolic heart faikure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953-1959. doi : 10.1056/NEJMoa032566